Romain Vazquez

The share of this author’s assessed papers carrying a ⚑ flag. A concentration is a prompt for expert review — never, on its own, a determination about the person.

Collaborators, sized by shared output and coloured by their own reproducibility (green = high, red = low). Click a node to open their card. A pattern is a prompt for review, never a determination.

How this author’s assessed papers reproduced — the outcome of reproduction attempts, not a judgement of the person. Coverage is partial and grows over time.

Assessed papers (1)

• Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia.⚑
  2025 L1 32/100 ⚑

1 assessed by us (0 reproduced) · 9 not yet assessed — every PubMed paper on record, linked below.

• High frequency of <scp>CD95</scp> ⁺ / <scp>CD45RA</scp> ⁻ regulatory T cells defines an immunosuppressive profile associated with <scp>MDS</scp> progression ↗

  British Journal of Haematology · 2026 · PMID 42080308
  not yet assessed
• Efficacy and safety of azacitidine for VEXAS syndrome: a large-scale retrospective study from FRENVEX ↗

  Blood · 2025 · PMID 40373272
  not yet assessed
• Pro-inflammatory role of granzyme K producing bystander CD8 ⁺ T cells in acute myeloid leukemia ↗

  bioRxiv (Cold Spring Harbor Laboratory) · 2025
  not yet assessed
• Integrated analysis of post-transcriptional regulations reveals insights into acute myeloid leukemia⚑

  Communications Biology · 2025 · PMID 41407883
  L1 32/100 ⚑
• Prédire les effets anti-leucémiques du venetoclax dans les LAM et les optimiser en ciblant la mitophagie dépendante de PINK1 ↗

  2024
  not yet assessed
• Dihydroartemisinin-induced ferroptosis in acute myeloid leukemia: links to iron metabolism and metallothionein ↗

  Cell Death Discovery · 2023 · PMID 36928207
  not yet assessed
• <scp>PCR‐Fluo‐<i>ASXL1</i>‐FA</scp>: A fast, sensitive and inexpensive complementary method to detect <scp><i>ASXL1</i></scp> mutations in haematological malignancies ↗

  International Journal of Laboratory Hematology · 2022 · PMID 35793805
  not yet assessed
• Effets de la dihydroartémisinine sur la régulation du métabolisme du fer et de la ferroptose dans les leucémies aiguës myéloïdes ↗

  2022
  not yet assessed
• Venetoclax combination therapy induces deep AML remission with eradication of leukemic stem cells and remodeling of clonal haematopoiesis ↗

  Blood Cancer Journal · 2021 · PMID 33741892
  not yet assessed
• High sensitivity of the Hematoflow™ solution for chronic myelomonocytic leukemia screening ↗

  Cytometry Part B Clinical Cytometry · 2017 · PMID 29108126
  not yet assessed